Thanks for the link mohuk.
I find whats most interesting is this..
Please fill out the form below if you are interested in participating in our next clinical trial.
Our clinical team has initiated discussions with regulators in Europe and North America in anticipation of positive data from our ongoing phase I/IIa clinical trial. Once approval to conduct those trials has been obtained, and clinical sites have been selected, there will be an opportunity for subjects to qualify to be study participants. Please note that subjects that qualify for study participation will be required to make frequent clinical site visits to ensure their safety and to monitor the effects of the RepliCel™ procedure, therefore, subject proximity to a trial site is an important consideration.
Why is everyone ready to write Replicel off?